Escape Plan From a Borderline Woman

When Your Loved One Has Borderline Personality Disorder

Get Instant Access

Akiskal HS (1981). Subaffective disorders: Dysthymic, cyclothymic, and bipolar II disorders in the "borderline" realm. Psychiatric Clin North Am 4:25-46. Allport GW (1961). Pattern and Growth in Personality: A Psychological Interpretation. Holt,

Rinehart, & Winston: New York. Allport GW, Odbert HS (1936). Trait-names: A psycho-lexical study. Psychol Monographs 47. Angst J, Ernst C (1993). Current concepts of the classification of affective disorders. Int Clin Psychopharmacol 8:211-215.

Asberg M, Traskman L, Thoren P (1976). 5-HIAA in the cerebrospinal fluid: A biochemical suicide predictor? Arch Gen Psychiatry 33:1193-1197.

Benjamin LS (1996). Interpersonal Diagnosis and Treatment of Personality Disorders. Guilford Press: New York.

Binet A (1905). New methods for the diagnosis of the intellectual level of subnormals. L'Annee Psychologique 12:191-244.

Blais MA, Norman DK (1997). A psychometric evaluation of the DSM-IV personality disorder criteria. J Pers Disorders 11:168-176.

Bouchard TJ (1994). Genes, environment, and personality. Science 264:1700-1701.

Bouchard TJ, Loehlin JC (2001). Genes, evolution, and personality. Behav Genetics 31:243273.

Brower MC, Price BH (2001). Neuropsychiatry of frontal lobe dysfunction in violent and criminal behaviour: A critical review. J Neurol Neurosurg Psychiatry 71:720-726.

Brown GL, Goodwin FK, Ballenger JC, Goyer PF, Major LF (1979). Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res 1:131 -139.

Canli T, Zhao Z, Desmond JE, Kang E, Gross JJ, Gabrieli JDE (2001). An FMRI study of personality influences on brain reactivity to emotional stimuli. Behav Neurosci 115:33-42.

Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinaer MC (1994). Putatively psychosisprone subjects 10 years later. J Abnormal Psychol 103:171-183.

Clark LA (1993). Manual for the Schedule for Nonadaptive and Adaptive Personality. University of Minnesota Press: Minneapolis.

Clark LA, Harrison JA (2001). Assessment instruments. In Livesley WJ (ed). Handbook of Personality Disorders: Theory, Research and Treatment. Guilford, New York, pp. 277-306.

Clark LA, Vorhies L, McEwen JL (1994). Personality disorder symptomatology from the five-factor model perspective. In Costa PT, Widiger TA (eds). Personality Disorders and the Five-Factor Model of Personality. American Psychological Association, Washington, DC, pp. 1-12.

Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. Arch Gen Psychiatry 44:579-588.

Cloninger CR, Svrakic DM, Przybeck TR (1993). A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975-990.

Cloninger CR, Van Eerdewegh P, Goate A, Edenberg HJ, Blangero J, Hesselbrock V, et al. (1998). Anxiety proneness linked to epistatic loci in genome scan of human personality traits. Am J Med Genet 81:313-317.

Coccaro EF (1998). Central neurotransmitter function in human aggression and impulsivity. In Maes M, Coccaro EF (eds). Neurobiology and Clinical Views on Aggression and Impulsivity. Wiley: Chichester, UK, pp. 143-168.

Coccaro EF (2001). Biological and treatment correlates. In Livesley WJ (ed). Handbook of Personality Disorders. Guilford Press: New York: pp. 124-135.

Coccaro EF, Kavoussi RJ (1997). Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch Gen Psychiatry 54:1081-1088.

Coccaro EF, Lawrence T, Trestman R, Gabriel S, Klar HM, Siever LJ (1991). Growth hormone responses to intravenous clonidine challenge correlates with behavioral irritability in psychiatric patients and in healthy volunteers. Psychiatry Res 39:129-139.

Coccaro EF, Kavoussi RJ, Hauger RL, Cooper TB, Ferris CF (1998). Cerebrospinal fluid vasopressin levels: Correlates with aggression and serotonin function in personality-disordered subjects. Arch Gen Psychiatry 55:708-714.

Costa PT, McCrae RR (1989). Normal personality assessment in clinical practice: The NEO Personality Inventory. Psychol Assess 4:5 -13.

Costa PT, McCrae RR (1992). Revised NEO Personality Inventory (NEO-PI-R) and the NEO Five-Factor Inventory (NEO-FFI) Professional Manual. Psychological Assessment Resources: Odessa, FL.

Costa PT, Widiger TA (1994). Personality Disorders and the Five-Factor Model of Personality. American Psychological Association: Washington, DC, p. 364.

Cowdry RW, Gardner DL (1988). Pharmacotherapy of borderline personality disorder: Alprazolam, carbamazepine, trifluroperazine, and tranylcypromine. Arch Gen Psychiatry 45:111119.

Davidson RJ, Putnam KM, Larson CL (2000). Dysfunction in the neural circuitry of emotion regulation—a possible prelude to violence. Science 289:591-594.

Davis KL, Panksepp J, Normansell L (2003). The affective neuroscience personality scales: Normative data and implications. Neuro-Psychoanalysis. 5:57-69.

De Raad B, Perugini M, Hrebickova M, Szarota P (1998). Lingua franca of personality: Taxonomies and structures based on the psycholexical approach. J Cross Cult Psychol 29:212232.

Depue R, Collins F (1999). Neurobiology of the structure of personality: Dopamine, facilitation of incentive motivation, and extraversion. Behav Brain Sci 22:491-569.

Depue R, Luciana M, Arbisi P, Collins P, Leon A (1994). Dopamine and the structure of personality: Relation of agonist-induced dopamine activity to positive emotionality. J Pers Soc Psychol 67:485-498.

Digman JM (1990). Personality structure: Emergence of the five-factor structure. Ann Rev Psychol 41:417-440.

Dolan-Sewell RT, Krueger RF, Shea MT (2001). Co-occurrence with syndrome disorders. In Livesley WJ (ed). Handbook of Personality Disorders. Guilford Press: New York, pp. 84-104.

Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, et al. (1996). Dopamine D4 receptor (DRD4) exon III polymorphism associated with the human personality trait of novelty seeking. Nature Genet 12:78-80.

Eysenck HJ (1987). The definition of personality disorders and the criteria appropriate to their definition. J Pers Dis 1:211-219.

Eysenc HJ, Eysenck S (1991). Eysenck Personality Questionnaire-Revised. Hodder, London.

Farah MJ (2002). Emerging ethical issues in neuroscience. Nature Neurosci 5:1123-1129.

Farde L, Gustavsson JP, Jonnsson E (1997). D2 dopamine receptors and personality traits. Nature 385:590.

Ferris CF, Melloni RHJ, Koppel G, Perry KW, Fuller RW, Delville Y (1997). Vasopressin/ serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J Neurosci 17:4331-4340.

Frances AJ, Mack AH, First MB, Widiger TA, Ross R, Forman L, et al. (1994). DSM-IV meets philosophy. J Med Philos 19:207-218.

Freedman MB, Leary TF, Ossorio AG, Coffey HS (1951). The interpersonal dimension of personality. J Pers 20:143-161.

Goldberg LR (1990). An alternative "description of personality": The Big Five factor structure. J Pers Soc Psychol 59:1216-1229.

Goldberg SC, Schulz SC, Schulz PM, Resnick RJ, Hamer RM, Friedel RO (1986). Borderline and schizotypal personality disorders treated with low-dose thiothixene versus placebo. Arch Gen Psychiatry 43:680-686.

Goyer PF, Andreason PJ, Semple WE, Clayton AH, King AC, Compton-Toth BA, et al. (1994). Positron-emission tomography and personality disorders. Neuropsychopharm 10:21-28.

Gross C, Zhuang X, Stark K, Ramboz S, Oosting R, Kirby L, et al. (2002). Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 416:396-400.

Heinz A, Mann K, Weinberger DR, Goldman D (2001). Serotonergic dysfunction, negative mood states, and response to alcohol. Alc Clin Exp Res 25:487-495.

Herbst JH, Zonderman AB, McCrae RR, Costa PT (2000). Do the dimensions of the Temperament and Character Inventory map a simple genetic architecture? Am J Psychiatry 157:1285-1290.

Horowitz LM, Rosenberg SE, Baer BA, Ureno G, Villasenor VS (1988). Inventory of interpersonal problems: Psychometric properties and clinical applications. J Cons Clin Psychol 56:885-892.

Jang KL, Vernon PA (2001). Genetics. In Livesley WJ (ed). Handbook of Personality Disorders. Guilford Press: New York, pp. 177-195.

Jang KL, Vernon PA, Livesley WJ (2000). Personality disorder traits, family environment, and alcohol misuse: A multivariate behavioural genetic analysis. Addiction 95:873-888.

Knutson B, Wolkowitz OM, Cole SW, Chan T, Moore EA, Johnson RC, et al. (1998). Selective alteration of personality and social behavior by serotonergic intervention. Am J Psychiatry 155:373-379.

Knutson B, Kaiser E, Westdorp A, Hommer D (1999). Personality predicts brain activation to incentives. NeuroImage 8:S360.

Lee KC, Kovac YS, Rhee H (1987). The national epidemiological study of mental disorders in Korea. J Korean Med Sci 2:19-34.

Lesch K-P, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al. (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274:1527-1531.

Leyton M, Boileau I, Benkelfat C, Diksic M, Baker G, Dagher A (2002). Amphetamine-induced increases in extracellular dopamine, drug wanting, and novelty seeking: A PET/[11C]raclo-pride study in healthy men. Neuropsychopharmacology 27:1027-1035.

Linnoila M, Charney DS (2000). The neurobiology of aggression. In Charney DS, Nestler EJ, Bunney BS (eds). Neurobiology of Mental Illness. Oxford University Press: New York, pp. 855-871.

Livesley WJ (2001). Handbook of Personality Disorders, Guilford Press: New York, pp. 626.

Livesley WJ, Jackson DN, Schroeder ML (1992). Factorial structure of traits delineating personality disorders in clinical and general population samples. J Abnorm Psychol 101:432-440.

Livesley WJ, Jang KL, Jackson DN, Vernon PA (1993). Genetic and environmental contributions to dimensions of personality disorder. Am J Psychiatry 50:1826-1831.

Livesley WJ, Schroeder ML, Jackson DN, Jang KL (1994). Categorical distinctions in the study of personality disorder: Implications for classification. J Abnorm Psychol 103:6-17.

Livesley WJ, Jang KL, Vernon PA (1998). Phenotypic and genetic structure of traits delineating personality disorder. Arch Gen Psychiatry 55:941-948.

Manuck SB, Flory JD, McCaffery JM, Matthews KA, Mann JJ, Muldoon MF (1998). Aggression, impulsivity, and central nervous system serotonergic responsivity in a nonpatient sample. Neuropsychopharmacology 19:287 -299.

Markovitz PJ (1995). Pharmacotherapy of impulsivity, aggression, and related disorders. In Stein D, Hollander E (eds). Impulsive Aggression and Disorders of Impulse Control. Wiley: Sussex, UK, pp. 263-287.

Mattia JI, Zimmerman M (2001). Epidemiology. In Livesley WJ (ed). Handbook of Personality Disorders: Theory, Research, and Treatment. Guilford Press: New York, pp. 107-123.

Murphy DL, Li Q, Engel S, Wichems C, Andrews A, Lesch K-P, et al. (2001). Genetic perspectives on the serotonin transporter. Brain Research Bulletin 56:487-494.

O'Boyle M, Self P (1990). A comparison of two interviews for DSM-III personality disorders. Psychiatric Res 32:283-285.

Oldham JM, Skodol AE, Kellman HD, Hyler SE, Doidge N, Rosnick L, et al. (1995). Comorbidity of axis I and axis II disorders. Am J Psychiatry 152:571-578.

Panksepp J (1998). Affective Neuroscience: The Foundations of Human and Animal Emotions. Oxford University Press: New York.

Passini FT, Norman WT (1966). A universal conception of personality structure? J Pers Soc Psychol 4:44-49.

Pavlov IP (1935). Physiology and Pathology of the Higher Nervous Functions. Academy of Sciences: Leningrad.

Plomin R, Chipheur HM, Loehlin JC (1990). Behavior genetics and personality. In Pervin LA (ed). Handbook of Personality: Theory and Research. Guilford Press: New York, pp. 225-243.

Reich W (1949). Character Analysis, 3rd ed. Farrar, Straus, & Giroux: New York.

Rinne T, van den Brink W, Wouters L, van Dyck R (2002). SSRI treatment of borderline personality disorder: A randomized, placebo-controlled clinical trial for female patients with borderline personality disorder. Am J Psychiatry 159:2048-2054.

Salzman C, Wolfson AN, Schatzberg A, Looper J, Henke R, Albanese M, et al. (1995). Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder. J Clin Psychopharmacol 15:23-29.

Sanderson C, Clarkin JF (1994). Use of the NEO-PI personality dimensions in differential treatment planning. In Costa PT, Widiger TA (eds). Personality Disorders and the Five-Factor Model of Personality. American Psychological Association Press: Washington, DC, pp. 219-236.

Sanislow CA, McGlashan TH (1998). Treatment outcome of personality disorders. Can J Psychiatry 43:237-250.

Schinka JA, Letsch EA, Crawford FC (2002). DRD4 and novelty seeking: Results of a meta-analysis. Am J Med Genetics 114:643-648.

Schroeder ML, Wormworth JA, Livesley WJ (1994). Dimensions of personality disorder and the five-factor model of personality. In Costa PT, Widiger TA (eds). Personality Disorders and the Five-Factor Model ofPersonality. American Psychological Association: Washington, DC, pp. 1-12.

Schulz SC, Cornelius J, Schulz PM, Soloff PH (1988). The amphetamine challenge test in patients with borderline personality disorder. Am J Psychiatry 145:809-814.

Sheard M, Marini J, Bridges C, Wapner A (1976). The effect of lithium on impulsive aggressive behavior in man. Am J Psychiatry 133:1409-1413.

Siegel RE (1968). Galen's System of Physiology and Medicine. Karger: Basel.

Siegel A, Roeling TA, Gregg TR, Kruk MR (1999). Neuropharmacology of brain-stimulation-evoked aggression. Neurosci Biobehav Rev 23:359-389.

Siever LJ, Davis KL (1991). A psychobiological perspective on the personality disorders. Am J Psychiatry 148:1647-1658.

Siever LJ, Amin F, Coccaro EF, Trestman R, Silverman T, Horath TB, et al. (1993). CSF ho-movanillic acid in schizotypal personality disorder. Am J Psychiatry 150:149-151.

Siever LJ, Buchsbaum MS, New AS, Spiegel-Cohen J, Wei T, Hazlett EA, et al. (1999). d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxy-glucose positron emission tomography. Neuropsychopharmacology 20:413-423.

Silk KR (1994). From first- to second-generation biological studies of borderline personality disorder. In Silk K (ed). Biological and Neurobehavioral Studies of Borderline Personality Disorder. American Psychiatric Press: Washington, DC, pp. xvii-xxix.

Soloff PH, Cornelius J, George A, Nathan S, Perel JM, Ulrich RF (1993). Efficacy of phenelzine and haloperidol in borderline personality disorder. Arch Gen Psychiatry 50:377-385.

Soloff PH, George A, Nathan Rs, Schulz PM, Ulrich RF, Perel JM (1986). Progress in the phar-macotherapy of borderline disorders: A double-blind study of amitriptyline, haloperidol, and placebo. Arch Gen Psychiatry 43:691-697.

Soloff PH, Meltzer CC, Greer PJ, Constantine D, Kelly TM (2000). A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol Psychiatry 47:540-547.

Steinberg BJ, Trestman R, Mitroupoulou V, Serby M Silverman J Collavo E, et al. (1997). Depressive response to physostigmine challenge in borderline personality disorder patients. Neuropsychopharmacology 17:264 - 273.

Suhara T, Yasuno F, Sudo Y, Yamamoto M, Inoue M, Yoshiro O, et al. (2001). Dopamine D2 receptors in the insular cortex and the personality trait of novelty seeking. NeuroImage 13:891-895.

Tauscher J, Bagby RM, Javanmard M, Christensen BK, Kasper S, Kapur S (2001). Inverse relationship between serotonin 5-HTJA receptor binding and anxiety: A [11C]WAY-100635 PET investigation in healthy volunteers. Am J Psychiatry 158:1326-1328.

Trull TJ, Widiger TA (1997). Structured Interview for the Five-Factor Model. Psychological Assessment Resources: Odessa, FL.

Tse WS, Bond AJ (2002). Serotonergic intervention affects both social dominance and affiliative behaviour. Psychopharmacology (Berlin) 161:324-330.

Tyrer P, Gunderson JG, Lyons M, Tohen M (1997). Special feature: Extent of comorbidity between mental state and personality disorders. J Pers Dis 11:242-259.

Valzelli L (1980). Psychobiology of Aggression and Violence. Raven: New York.

Virkkunen M, Nuutila A, Goodwin FK, Linnoila M (1987). Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry 44:241 -247.

Widiger TA, Frances AJ, Harris M, Jacobsberg L, Fyer M, Manning D (1991). Comorbidity among Axis II disorders. In Oldham J (ed). Personality Disorders: New Perspectives on Diagnostic Validity. American Psychiatric Press: Washington, DC, pp. 163-194.

Wiggins JS, Trapnell PD, Phillips N (1988). Psychometric and geometric characteristics of the revised Interpersonal Adjective Scales (IAS-R). 23:517-530. Wundt W (1896). Grundriss der Psychologie. Wilhelm Engelmann: Leipzig. Zimmerman M, Coryell W (1989). DSM-III personality disorder diagnoses in a nonpatient sample: Demographic correlates and comorbidity. Arch Gen Psychiatry 46:682-689.

Was this article helpful?

0 0
Anxiety and Depression 101

Anxiety and Depression 101

Everything you ever wanted to know about. We have been discussing depression and anxiety and how different information that is out on the market only seems to target one particular cure for these two common conditions that seem to walk hand in hand.

Get My Free Ebook

Post a comment